MASIMasimo Corporation

$9B

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$229M+8.8% YoY

Gross Profit

$156M68.2% margin

Operating Income

$52M22.5% margin

Net Income

$49M21.4% margin

EPS (Diluted)

$0.86

QoQ Revenue Growth

-0.3%

Cash Flow

Operating Cash Flow

$51M

Free Cash Flow

$41M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$206M

Stockholders' Equity

$1.1B

Cash & Equivalents

$513M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$229M	$211M	+8.8%
Gross Profit	$156M	$141M	+11.0%
Operating Income	$52M	$49M	+6.1%
Net Income	$49M	$57M	-14.1%

Geographic Segments

UNITED STATES

$158M69%

EMEA

$42M19%

Asia Pacific

$23M10%

Americas

$6M3%

MASI Q3 2019 Earnings — Masimo Corporation Revenue & Financial Results | Market Cap Arena